Mealey's (September 18, 2020, 10:13 AM EDT) -- LOS ANGELES — A federal judge in California on Sept. 2 ordered lead plaintiffs in a securities class action to further clarify which alleged misstatements the lead plaintiffs contend a medical technology company and two of its senior officers made in concealing the source of the company's sales numbers in violation of federal securities laws (In re Inogen Inc. Securities Litigation, No. 19-1643, C.D. Calif., 2020 U.S. Dist. LEXIS 161982)....